# DarkJade Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/darkjade-sciences

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Angel (May 30, 2022)
- Investors on record: 2

## About

Based in Hangzhou, China, and founded in 2022, Darkjade Sciences is a biomedical company that provides organoid intelligent devices and chips. It has a pipeline production base in Wuhan and has cooperation with Peking University Affiliated Cancer Hospital, Huazhong University of Science and Technology Affiliated Tongji Hospital, etc. The researchers come from Harvard University and the Massachusetts Institute of Technology. The co-founder and Chief Scientist Officer, Yiwei Li, is a professor at the School of Life Science and Technology, Huazhong University of Science and Technology. In October 2025, Darkjade Sciences raised Pre-Series A++ funding from new investor TigerYeah Capital.
The company is committed to developing organoids intelligent devices, chips, and biopharmaceutical technology commercial application platforms. The products include intelligent devices for organoids, organoid chips, and test kits, organoid databases, etc. The organoid chips can be applied in disease modeling, toxicity testing, and other industries.
Revenue is generated through the sale of organoid chips and devices, reagent kits, clinical testing services, and licensing of its AI software systems. Additional income may come from partnerships with hospitals, pharmaceutical companies, and research institutions.

## Funding rounds

- Angel, May 30, 2022 — HSG, TigerYeah Capital

## Investors

- HSG (https://capitalatlas.ai/funds/hsg) — Angel
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel